Navigation Links
Mushroom found to be a source of a new antibiotic: Plectasin

Animals and higher plants are known to express endogenous peptide antibiotics called defensins, which are small cysteine-rich peptides found to be active against bacteria, fungi and viruses//.

A recent research, published in the October issue of Nature, describes plectasin-the first defensin to be isolated from a fungus, the saprophytic ascomycete Pseudoplectania nigrella. Plectasin has primary, secondary and tertiary structures that closely resemble those of defensins found in spiders, scorpions, dragonflies and mussels. Recombinant plectasin was produced at a very high, and commercially viable, yield and purity at the Danish biotechnology company Novozymes.

During the studies, the compound showed potent activity against a range of Gram-positive bacteria, including several strains resistant to conventional antibiotics, but was found less effective against Gram-negative microbes, the researchers noted.

In mice inoculated with a potentially lethal dose of S. pneumoniae in the peritoneum, plectasin was as effective as vancomycin. Plectasin treated mice were more likely to be alive seven days after infection compared with mice in the control arm. In a mouse model of pneumonia, plectasin and penicillin again had comparable efficacy, the researchers found.

The compound showed no evidence of toxicity in the mice, and is excreted without change in the urine of mice, which is a sign that it is safe and effective. However, the authors add that further study will be needed to see if it is safe to use in humans.

The results indicate that Plectasin showed extremely low toxicity in mice, and cured them of experimental peritonitis and pneumonia caused by S. pneumoniae as efficaciously as vancomycin and penicillin.

The authors conclude on the note that these findings identify fungi as a novel source of antimicrobial defensins, and show the therapeutic potential of plectasin. They also suggest that the defensins of insects
'"/>




Page: 1 2

Related medicine news :

1. Mushroom and muscle loss
2. Mushrooms can help fight chronic disease
3. Mushroom found to contain powerful antibiotic
4. Novel Vitamin D source in Mushrooms!
5. Mushrooms are Rich Source of Antioxidants
6. A Mushroom Extract May Impact the Body’s Immune Syste
7. Four of Family Died After Consuming Poisonous Mushrooms
8. Mushroom Extract Protects Poultry From Parasite Diseases
9. Magic Mushrooms Treat Obsessive Compulsion Disorder
10. Private Health-care Clinics Mushroom in Ontario
11. Much Room for Cancer Cure in a Mushroom, Scientists Promise
Post Your Comments:
(Date:7/9/2008)... Radiotherapy Clinics of Georgia (RCOG) has beg...ing campaign. RCOG is renowned for their ProstRcis...st documented prostate cancer cure rates in the wo...B) July 9, 2008 -- Radiotherapy Clinics of Georgia...r click campaign that incorporates geo targeting f...
(Date:7/9/2008)... This first-of-its-kind Diamond Elite Walk In ...aze, chip or develop cracks. , ...wo years in development, The Kitchen Bath Store ( ...e newest design in walk-in tubs: Diamond Elite Wa...nch-high entry and is 3-times thicker and stronger...
(Date:7/9/2008)... While SmartLipo has swept the nation with its ... removal procedure has leaped forward. Colorado pl...to be the first in his state to offer the next gen...o one of only two plastic surgeons authorized to t...e. , Lone Tree, CO (PRWEB...
(Date:7/9/2008)...w figures on assisted reproduction technology (ART...in the use of ICSI (intracytoplasmic sperm injecti...of the European Society of Human Reproduction and ...sday). Researchers believe that some countries may... the most recent year for which data have been co...
Breaking Medicine News(10 mins):Health News:Localized Online Marketing Campaign Serves to Raise Awareness of Prostate Cancer Treatment 2Health News:Localized Online Marketing Campaign Serves to Raise Awareness of Prostate Cancer Treatment 3Health News:The Kitchen Bath Store Releases Newest Design in Walk-In Tubs 2Health News:The Kitchen Bath Store Releases Newest Design in Walk-In Tubs 3Health News:John A. Millard, M.D. is 1st Surgeon in Colorado to Offer Smartlipo MPX™ 2Health News:John A. Millard, M.D. is 1st Surgeon in Colorado to Offer Smartlipo MPX™ 3Health News:Researcher say that ICSI may be over-used in some countries 2Health News:Researcher say that ICSI may be over-used in some countries 3
...test developed by a team led by a University of Le...rnment’s Independent Depleted Uranium// Oversight ...uranium (DU) during the 1991 Gulf Conflict. Ra...ology, developed the test with Postdoctoral Fellow...
...udying the genetic make-up using blood samples to ...g treatment, has been in practice//. Now, scientis...thods based on such existing tests that might reve...come victims of substance abuse or suffer antisoci...
...University of Iowa study has revealed that it may ...ions like panic disorder with blood tests//. This ...information in immature white blood cells. "The ...quantum leap in psychiatry," said the study's lead...
...searchers in the United States have developed a me...ll four types of the dengue// virus. The dengue v...cephalitis. The four types of virus are all suffic...iduals vaccinated against one virus type are still...
Other Medicine News:Health News:DU Test Finds UK Troops Uranium Free 2Health News:Genetic Tests to Reveal ‘substance Abuse’ Tendenci 2Health News:Genetic Tests to Reveal ‘substance Abuse’ Tendenci 3Health News:Mental Health Conditions Could Be Detected With Blood Tests 2
(Date:7/8/2008)...RNewswire/ -- Avir Green Hills Biotechnology,start...cine deltaFLU,against pandemic influenza. This nov...n the deletion of the NS1 gene has shown superior,...e biotech company sets,yet another milestone in th...m of Phase I Study, The randomized, double-blind ...
(Date:7/8/2008).../- After meeting on July 1st and,2nd ...betes drugs should,undergo trials to rule out card...f US endocrinologists agree with this recommendati...diovascular and metabolic primary market,research ...obal Life,Sciences Industry., On July 3rd AlphaDe...
(Date:7/8/2008)...eets primary endpoints in ENGAGE Trial, KENILWORT...-Plough,Corp., (NYSE: SGP ) announced today that ...follicle stimulant (SFS) met its primary endpoints...presented during a,Schering-Plough-sponsored sympo...ciety of Human Reproduction and Embryology (ESHRE)...
(Date:7/7/2008)...proves Cognition and is Well Tolerated in ...ndings Warrant Further Development in Huntington,s...Today at 5:00 p.m. EDT -, SAN FRANCISCO, July 7 /... MDVN ) today announced top-line results of a Pha...imebon(TM) significantly improved cognitive,functi...
Breaking Medicine Technology:Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU 2Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU 3AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panel's Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications. 2Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant 2Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant 3Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 2Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 3Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 4Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 5UCR plant cell biologist to study how plant stem cells maintain and change their identity 297 1UCR plant cell biologist to study how plant stem cells maintain and change their identity 297 2Prime Therapeutics Receives TIPPS Certification 729 1Prime Therapeutics Receives TIPPS Certification 729 2Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences 727 1Standard Management Announces OTCBB Listing 725 1Standard Management Announces OTCBB Listing 725 2
...monstrate Significant Survival Benefit in,Liver Ca...ll/ -- Bayer,HealthCare Pharmaceuticals Inc. and O...avar(R) (sorafenib) tablets significantly,extended...carcinoma,(HCC), or primary liver cancer versus th...). Results were presented at the 43rd,annual meeti...
...NESS WIRE)--Jun 4, 2007 - GenVec, Inc.,(Nasdaq: GN...y and,efficacy data from the clinical development ...nted in a poster session on,gastrointestinal cance...linical Oncology in Chicago, IL by Dr. Mitchell Po...sion of the posters then,concluded the Saturday mo...
Other Medicine Technology:Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 2Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 3Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 4Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 7GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 2GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 3GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 4
...igation system for ENT, cranial and spine procedur...y, critical zones visible during tracking. Image f...n freezes image, snapshot can be taken of frozen i...the microscope, low profile receiver attachment. A...
The spinal system neon is a modular system for posterior stabilization. Its application range extends from occipitocervical via cervical to cervicothoracic applications. In the case of children, it c
Bacon Cranial Rongeur
Cushing Pituitary Rongeur
Medicine Products: